A herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression

eLife

Volumn 5, Issue NOVEMBER2016, 2016, Pages

  Greene, Trever T ^a   Tokuyama, Maria ^a   Knudsen, Giselle M ^b   Kunz, Michele ^a   Lin, James ^a   Greninger, Alexander L ^b   Defilippis, Victor R ^c   Derisi, Joseph L ^b   Raulet, David H ^a   Coscoy, Laurent ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDO 2 (2 METHOXYETHOXY)ACETOPHENONE; CASEIN KINASE II; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; NATURAL KILLER CELL RECEPTOR NKG2D; HISTONE DEACETYLASE 3; KLRK1 PROTEIN, MOUSE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; NUCLEAR MATRIX PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; RAE1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GEL MOBILITY SHIFT ASSAY; GENE; HISTONE ACETYLATION; IMMUNOFLUORESCENCE TEST; LIQUID CHROMATOGRAPHY; LUCIFERASE ASSAY; MASS SPECTROMETRY; MOLECULAR CLONING; MOUSE; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PLAQUE ASSAY; PROTEIN EXPRESSION; RAE 1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MUROMEGALOVIRUS; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS;

EID: 85001085888     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.14749     Document Type: Article

References (58)

1. Bekerman E, Jeon D, Ardolino M, Coscoy L. 2013. A role for host activation-induced cytidine deaminase in innate immune defense against KSHV. PLoS Pathogens 9:e1003748. doi: 10.1371/journal.ppat.1003748 PMID: 24244169
2. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. New England Journal of Medicine 320:1731–1735. doi: 10.1056/NEJM198906293202605 PMID: 2543925
3. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM. 1991. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. Journal of Clinical Investigation 88:1613–1621. doi: 10.1172/JCI115474 PMID: 1834700
4. Borst EM, Benkartek C, Messerle M. 2007. Use of bacterial artificial chromosomes in generating targeted mutations in human and mouse cytomegaloviruses. Current Protocols in Immunology Chapter 10:32. doi: 10.1002/0471142735.im1032s77 PMID: 18432982
5. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721–727. doi: 10.1016/S1074-7613(00)80222-8 PMID: 10894171
6. Chalkley RJ, Baker PR, Medzihradszky KF, Lynn AJ, Burlingame AL. 2008. In-depth analysis of tandem mass spectrometry data from disparate instrument types. Molecular & Cellular Proteomics 7:2386–2398. doi: 10.1074/mcp.M800021-MCP200 PMID: 18653769
7. Champsaur M, Lanier LL. 2010. Effect of NKG2D ligand expression on host immune responses. Immunological Reviews 235:267–285. doi: 10.1111/j.0105-2896.2010.00893.x PMID: 20536569
8. Elias JE, Gygi SP. 2007. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nature Methods 4:207–214. doi: 10.1038/nmeth1019 PMID: 17327847
9. Gasser S, Orsulic S, Brown EJ, Raulet DH. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436:1186–1190. doi: 10.1038/nature03884 PMID: 15995699
10. Ghavidel A, Schultz MC. 2001. TATA binding protein-associated CK2 transduces DNA damage signals to the RNA polymerase III transcriptional machinery. Cell 106:575–584. doi: 10.1016/S0092-8674(01)00473-1 PMID: 11551505
11. Glozak MA, Seto E. 2007. Histone deacetylases and cancer. Oncogene 26:5420–5432. doi: 10.1038/sj.onc.1210610 PMID: 17694083
12. González S, López-Soto A, Suarez-Alvarez B, López-Vázquez A, López-Larrea C. 2008. NKG2D ligands: key targets of the immune response. Trends in Immunology 29:397–403. doi: 10.1016/j.it.2008.04.007
13. Greninger AL, Knudsen GM, Betegon M, Burlingame AL, Derisi JL. 2012. The 3A protein from multiple picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIb. Journal of Virology 86:3605–3616. doi: 10.1128/JVI.06778-11 PMID: 22258260
14. Gu H, Liang Y, Mandel G, Roizman B. 2005. Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. PNAS 102:7571–7576. doi: 10.1073/pnas.0502658102 PMID: 15897453
15. Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Greenberg NR, Raulet DH. 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28:571–580. doi: 10.1016/j.immuni.2008.02.016 PMID: 18394936
16. Hellwig CT, Ludwig-Galezowska AH, Concannon CG, Litchfield DW, Prehn JH, Rehm M. 2010. Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation. Journal of Cell Science 123:1401–1406. doi: 10.1242/jcs.061143 PMID: 20356928
17. Holtappels R, Grzimek NK, Thomas D, Reddehase MJ. 2002. Early gene m18, a novel player in the immune response to murine cytomegalovirus. Journal of General Virology 83:311–316. doi: 10.1099/0022-1317-83-2-311 PMID: 11807223
18. Homma MK, Homma Y. 2008. Cell cycle and activation of CK2. Molecular and Cellular Biochemistry 316:49–55. doi: 10.1007/s11010-008-9823-4 PMID: 18649047
19. Jonjic´ S, Babic´ M, Polic´ B, Krmpotic´ A. 2008. Immune evasion of natural killer cells by viruses. Current Opinion in Immunology 20:30–38. doi: 10.1016/j.coi.2007.11.002 PMID: 18206359
20. Jung H, Hsiung B, Pestal K, Procyk E, Raulet DH. 2012. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. Journal of Experimental Medicine 209:2409–2422. doi: 10.1084/jem.20120565 PMID: 23166357
21. Juranic Lisnic V, Babic Cac M, Lisnic B, Trsan T, Mefferd A, Das Mukhopadhyay C, Cook CH, Jonjic S, Trgovcich J. 2013. Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interface. PLoS Pathogens 9:e1003611. doi: 10.1371/journal.ppat.1003611 PMID: 24086132
22. Karijolich J, Zhao Y, Peterson B, Zhou Q, Glaunsinger B. 2014. Kaposi’s sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2. Journal of Virology 88:7024–7035. doi: 10.1128/JVI.00931-14 PMID: 24719417
23. Kattenhorn LM, Mills R, Wagner M, Lomsadze A, Makeev V, Borodovsky M, Ploegh HL, Kessler BM. 2004. Identification of proteins associated with murine cytomegalovirus virions. Journal of Virology 78:11187–11197. doi: 10.1128/JVI.78.20.11187-11197.2004 PMID: 15452238
24. Khairallah C, Netzer S, Villacreces A, Juzan M, Rousseau B, Dulanto S, Giese A, Costet P, Praloran V, Moreau JF, Dubus P, Vermijlen D, Dé chanet-Merville J, Capone M, Al G. 2015. gd T cells confer protection against murine cytomegalovirus (MCMV). PLoS Pathogens 11:e1004702. doi: 10.1371/journal.ppat.1004702 PMID: 25747674
25. Lacaze P, Forster T, Ross A, Kerr LE, Salvo-Chirnside E, Lisnic VJ, López-Campos GH, García-Ramírez JJ, Messerle M, Trgovcich J, Angulo A, Ghazal P. 2011. Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes. Journal of Virology 85:6065–6076. doi: 10.1128/JVI.02341-10 PMID: 21471238
26. Litchfield DW. 2003. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochemical Journal 369:1–15. doi: 10.1042/bj20021469 PMID: 12396231
27. Liu XF, Yan S, Abecassis M, Hummel M. 2010. Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivo. Journal of Virology 84: 3631–3643. doi: 10.1128/JVI.02380-09 PMID: 20106920
28. Liu XV, Ho SSW, Tan JJ, Kamran N, Gasser S. 2012. Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands. Journal of Immunology 189:1826–1834. doi: 10.4049/jimmunol.1200965 PMID: 22798674
29. Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier LL. 2003. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. Journal of Experimental Medicine 197:1245–1253. doi: 10.1084/jem.20021973 PMID: 12756263
30. Lodoen MB, Lanier LL. 2006. Natural killer cells as an initial defense against pathogens. Current Opinion in Immunology 18:391–398. doi: 10.1016/j.coi.2006.05.002 PMID: 16765573
31. López-Soto A, Folgueras AR, Seto E, Gonzalez S. 2009. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. Oncogene 28: 2370–2382. doi: 10.1038/onc.2009.117
32. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, Buchman S, Chen CY, Chou A, Ienasescu H, Lim J, Shyr C, Tan G, Zhou M, Lenhard B, Sandelin A, Wasserman WW. 2014. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Research 42:D142–D147. doi: 10.1093/nar/gkt997 PMID: 24194598
33. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y. 1997. Selective switch between latency and lytic replication of Kaposi’s sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. Journal of Virology 71:314–324. PMID: 8985352
34. Murphy JC, Fischle W, Verdin E, Sinclair JH. 2002. Control of cytomegalovirus lytic gene expression by histone acetylation. The EMBO Journal 21:1112–1120. doi: 10.1093/emboj/21.5.1112 PMID: 11867539
35. Nevels M, Paulus C, Shenk T. 2004. Human cytomegalovirus immediate-early 1protein facilitates viral replication by antagonizing histone deacetylation. PNAS 101:17234–17239. doi: 10.1073/pnas.0407933101 PMID: 15572445
36. Patil H, Wilks C, Gonzalez RW, Dhanireddy S, Conrad-Webb H, Bergel M. 2016. Mitotic activation of a novel histone deacetylase 3-linker histone H1.3 protein complex by protein kinase CK2. Journal of Biological Chemistry 291:3158–3172. doi: 10.1074/jbc.M115.643874 PMID: 26663086
37. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. 2013. Regulation of ligands for the NKG2D activating receptor. Annual Review of Immunology 31:413–441. doi: 10.1146/annurev-immunol-032712-095951 PMID: 23298206
38. Raulet DH, Guerra N. 2009. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nature Reviews Immunology 9:568–580. doi: 10.1038/nri2604 PMID: 19629084
39. Raulet DH. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nature Reviews Immunology 3:781–790. doi: 10.1038/nri1199 PMID: 14523385
40. Roszak A, Lianeri M, Jagodziński PP. 2012. Prevalence of the NKG2D Thr72Ala polymorphism in patients with cervical carcinoma. Genetic Testing and Molecular Biomarkers 16:841–845. doi: 10.1089/gtmb.2011.0308 PMID: 22480139
41. Ruzzene M, Penzo D, Pinna LA. 2002. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochemical Journal 364:41–47. doi: 10.1042/bj3640041 PMID: 11988074
42. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nature Methods 9:676–682. doi: 10.1038/nmeth.2019 PMID: 22743772
43. Shin HJ, DeCotiis J, Giron M, Palmeri D, Lukac DM. 2014. Histone deacetylase classes I and II regulate Kaposi’s sarcoma-associated herpesvirus reactivation. Journal of Virology 88:1281–1292. doi: 10.1128/JVI.02665-13 PMID: 24227836
44. Shinoda K, Ohyama K, Hasegawa Y, Chang HY, Ogura M, Sato A, Hong H, Hosono T, Sharp LZ, Scheel DW, Graham M, Ishihama Y, Kajimura S. 2015. Phosphoproteomics Identifies CK2 as a Negative Regulator of Beige Adipocyte Thermogenesis and Energy Expenditure. Cell Metabolism 22:997–1008. doi: 10.1016/j.cmet.2015.09.029 PMID: 26525534
45. Smith LM, McWhorter AR, Masters LL, Shellam GR, Redwood AJ. 2008. Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus. Journal of Virology 82:6689–6696. doi: 10.1128/JVI.00160-08 PMID: 18417589
46. Smith MC, Bayless AM, Goddard ET, Davido DJ. 2011. CK2 inhibitors increase the sensitivity of HSV-1 to interferon-b. Antiviral Research 91:259–266. doi: 10.1016/j.antiviral.2011.06.009 PMID: 21722672
47. Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y. 2005a. Activation of NK cell cytotoxicity. Molecular Immunology 42:501–510. doi: 10.1016/j.molimm.2004.07.034 PMID: 15607806
48. Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y. 2005b. NKG2D function protects the host from tumor initiation. Journal of Experimental Medicine 202:583–588. doi: 10.1084/jem.20050994 PMID: 16129707
49. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. 2006. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clinical Infectious Diseases 43:1143–1151. doi: 10.1086/508173 PMID: 17029132
50. Taniguchi R, Koyano S, Suzutani T, Goishi K, Ito Y, Morioka I, Nakamura H, Yamada H, Oka A, Inoue N. 2015. A Thr72Ala polymorphism in the NKG2D gene is associated with early symptomatic congenital cytomegalovirus disease. Infection 43:353–359. doi: 10.1007/s15010-015-0774-x PMID: 25861030
51. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40:191–197. doi: 10.2144/000112096 PMID: 16526409
52. Tokuyama M, Lorin C, Delebecque F, Jung H, Raulet DH, Coscoy L. 2011. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. PLoS Pathogens 7:e1002265. doi: 10.1371/journal.ppat.1002265 PMID: 21966273
53. Wald A, Corey L. 2007. Chapter 36 Persistence in the population: epidemiology, transmission. In: Arvin A, Campadelli-Fiume G, Mocarski E (Eds). Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press.
54. West AC, Johnstone RW. 2014. New and emerging HDAC inhibitors for cancer treatment. Journal of Clinical Investigation 124:30–39. doi: 10.1172/JCI69738 PMID: 24382387
55. Wilson AJ, Chueh AC, Tögel L, Corner GA, Ahmed N, Goel S, Byun DS, Nasser S, Houston MA, Jhawer M, Smartt HJ, Murray LB, Nicholas C, Heerdt BG, Arango D, Augenlicht LH, Mariadason JM. 2010. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Research 70:609–620. doi: 10.1158/0008-5472.CAN-09-2327 PMID: 20068171
56. Won J, Yim J, Kim TK. 2002. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. Journal of Biological Chemistry 277:38230–38238. doi: 10.1074/jbc.M206064200 PMID: 12151407
57. Young L, Sung J, Stacey G, Masters JR. 2010. Detection of Mycoplasma in cell cultures. Nature Protocols 5:929–934. doi: 10.1038/nprot.2010.43 PMID: 20431538
58. Zhang X, Ozawa Y, Lee H, Wen YD, Tan TH, Wadzinski BE, Seto E. 2005. Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes & Development 19:827–839. doi: 10.1101/gad.1286005 PMID: 15805470